Status:
UNKNOWN
Measured vs Navigated Techniques in Total Hip Arthroplasty
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
FormusLab
Conditions:
Osteoarthritis, Hip
Eligibility:
All Genders
Phase:
NA
Brief Summary
Accurate reconstruction of the native hip parameters following total hip arthroplasty is associated with improved outcome. In order to improve ability for optimum reconstruction, 3-D templating softwa...
Eligibility Criteria
Inclusion
- Patients who are signed for a THA for primary or secondary osteoarthritis without overt deformity that would require revision type implants and with good enough bone quality to be listed for uncemented component implantation.
Exclusion
- Secondary OA due to Dysplasia (Hartofilakidis \>1)
- Avascular necrosis of the hip with destruction of joint structure
- Sequelae of Pediatric deformity with abnormal anatomy
- Cemented fixation of femur or acetabulum
- Previous arthroplasty-type procedure
- Previous septic arthritis of the hip
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05393778
Start Date
July 1 2022
End Date
September 1 2024
Last Update
May 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.